MDR — Medadvisor Income Statement
0.000.00%
Last trade - 00:00- AU$52.98m
- AU$59.48m
- AU$122.11m
- 51
- 86
- 10
- 48
Annual income statement for Medadvisor, fiscal year end - June 30th, AUD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | 2024 June 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 11.1 | 40.3 | 67.8 | 98 | 122 |
| Cost of Revenue | |||||
| Gross Profit | 9.85 | 22.8 | 35 | 59.4 | 74.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 20.7 | 57.1 | 85.5 | 109 | 121 |
| Operating Profit | -9.66 | -16.8 | -17.7 | -10.6 | 0.924 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -9.78 | -17.2 | -17.7 | -10.5 | 0.924 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -9.78 | -14.4 | -17.5 | -11.3 | 0.792 |
| Minority Interest | |||||
| Net Income Before Extraordinary Items | |||||
| Net Income | -9.59 | -13.9 | -17.3 | -11.3 | 0.792 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -9.59 | -13.9 | -17.3 | -11.3 | 0.792 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.041 | -0.044 | -0.046 | -0.021 | 0.001 |